Monitoring Tafamidis, The Most Expensive Cardiac Medication: Are Serum Transthyretin Levels the Answer?

[Figure: see text]

Detalles Bibliográficos
Autores principales: Chang, Ian C., Muchtar, Eli, Grogan, Martha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543139/
https://www.ncbi.nlm.nih.gov/pubmed/34729531
http://dx.doi.org/10.1016/j.jaccao.2021.09.007
_version_ 1784589579384258560
author Chang, Ian C.
Muchtar, Eli
Grogan, Martha
author_facet Chang, Ian C.
Muchtar, Eli
Grogan, Martha
author_sort Chang, Ian C.
collection PubMed
description [Figure: see text]
format Online
Article
Text
id pubmed-8543139
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-85431392021-11-01 Monitoring Tafamidis, The Most Expensive Cardiac Medication: Are Serum Transthyretin Levels the Answer? Chang, Ian C. Muchtar, Eli Grogan, Martha JACC CardioOncol Original Research [Figure: see text] Elsevier 2021-10-19 /pmc/articles/PMC8543139/ /pubmed/34729531 http://dx.doi.org/10.1016/j.jaccao.2021.09.007 Text en © 2021 Published by Elsevier on behalf of the American College of Cardiology Foundation. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Research
Chang, Ian C.
Muchtar, Eli
Grogan, Martha
Monitoring Tafamidis, The Most Expensive Cardiac Medication: Are Serum Transthyretin Levels the Answer?
title Monitoring Tafamidis, The Most Expensive Cardiac Medication: Are Serum Transthyretin Levels the Answer?
title_full Monitoring Tafamidis, The Most Expensive Cardiac Medication: Are Serum Transthyretin Levels the Answer?
title_fullStr Monitoring Tafamidis, The Most Expensive Cardiac Medication: Are Serum Transthyretin Levels the Answer?
title_full_unstemmed Monitoring Tafamidis, The Most Expensive Cardiac Medication: Are Serum Transthyretin Levels the Answer?
title_short Monitoring Tafamidis, The Most Expensive Cardiac Medication: Are Serum Transthyretin Levels the Answer?
title_sort monitoring tafamidis, the most expensive cardiac medication: are serum transthyretin levels the answer?
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8543139/
https://www.ncbi.nlm.nih.gov/pubmed/34729531
http://dx.doi.org/10.1016/j.jaccao.2021.09.007
work_keys_str_mv AT changianc monitoringtafamidisthemostexpensivecardiacmedicationareserumtransthyretinlevelstheanswer
AT muchtareli monitoringtafamidisthemostexpensivecardiacmedicationareserumtransthyretinlevelstheanswer
AT groganmartha monitoringtafamidisthemostexpensivecardiacmedicationareserumtransthyretinlevelstheanswer

Ejemplares similares